StephanieMehlisMD

Dermatology • Skokie, IL

Director, Dermatology Clinical Trials Unit

Join to view full profile

Dr. Mehlis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mehlis' full profile

Already have an account?

Office
9933 Woods Dr
2nd Floor - Dermatology
Skokie, IL 60077
Phone+1 847-663-8060
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 2003 - 2006
Northwestern University The Feinberg School of MedicineClass of 2001

Certifications & Licensure

IL State Medical License 2001 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Psoriasis Longitudinal Assessment and Registry Start of enrollment: 2007 Jun 21
Active, not recruiting
A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) Start of enrollment: 2012 Jul 28
Completed
Phase 3
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab Start of enrollment: 2014 Oct 07
Completed
Phase 3
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment Start of enrollment: 2014 Nov 03
Completed
Phase 3
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment Start of enrollment: 2016 Feb 29
Completed
Phase 3
Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) Start of enrollment: 2022 May 06
Withdrawn
Phase 3
Roles: Contact, Principal Investigator
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis.
Stephanie L Mehlis, Joel C Joyce, Zi-Yi Choo> ;Disease-a-Month. 2024 Apr 1
1 citations
Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab.
Adesola A Akinyemi, Thomas Cibull, Stephanie Mehlis, Jason B Waldinger, Zi-Yi Choo> ;JAAD Case Reports. 2023 Mar 1
3 citations
Do regional geography and race influence management of chronic spontaneous urticaria?
Giselle S Mosnaim, Matthew Greenhawt, Polina Imas, Loretta Au, Stephanie Mehlis, John Oppenheimer, David Lang, Jonathan Bernstein, Marcus Shaker> ;The Journal of Allergy and Clinical Immunology. 2022 Dec 1
1 citations
An unusual case of calciphylaxis in a psoriatic patient without kidney disease
Maria L. Mihailescu, Stephanie L Mehlis> ;JAAD Case Reports. 2021 Feb 2
43 citations
Biologics for the primary care physician: Review and treatment of psoriasis.
Bernhard Ortel, Stephanie L Mehlis> ;Disease-a-Month. 2019 Mar 1
2 citations
Two cases of treatment with aromatase inhibitors and development of miliary osteoma cutis-Is there an association?
Stephanie L Mehlis, Thomas L. Cibull, Bernhard Ortel> ;JAAD Case Reports. 2018 Aug 1
A Severe Case of Minocycline-induced Hyperpigmentation of the Lower Extremities.
Thomas L. Cibull, Stephanie L Mehlis> ;Cureus. 2018 May 22
16 citations
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psor...
Andrew Blauvelt, Kristian Reich, Stephanie L Mehlis, Francisco Vanaclocha, Howard Sofen, W Abramovits, Yang Zhao, Isabelle Gilloteau, E Davenport, Nicole Williams, Adr...> ;Journal of the European Academy of Dermatology and Venereology. 2017 Aug 8
98 citations
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Alice B. Gottlieb, C. Leonardi, Francisco A. Kerdel, Stephanie L Mehlis, M. Olds, David A. Williams> ;The British Journal of Dermatology. 2011 Sep 1
Pruritic, papular eruption, and concomitant neurologic symptoms: Churg-Strauss syndrome presenting with mononeuritis multiplex.
Jyoti Pathria, James Collyer, Stephanie L Mehlis, Joaquin Brieva> ;Skinmed. 2010 Mar 1
29 citations
Treating psoriasis with adalimumab.
Eihab Alwawi, Stephanie L Mehlis, Kenneth B. Gordon> ;Therapeutics and Clinical Risk Management. 2008 Apr 1
9 citations
From laboratory to clinic: rationale for biologic therapy
Stephanie L Mehlis, Kenneth B. Gordon> ;Dermatologic Clinics. 2004 Oct 1
63 citations
The immunology of psoriasis and biologic immunotherapy
Stephanie L Mehlis, Kenneth B. Gordon> ;Journal of the American Academy of Dermatology. 2003 Aug 1
Join now to see all

Journal Articles

Biologics for the Primary Care Physician: Review and Treatment of Psoriasis
Stephanie L Mehlis, Eric D Schadler, Bernhard Ortel, ScienceDirect

Other

Guttate psoriasis
Mehlis S
http://www.uptodate.com/contents/guttate-psoriasis
UpToDate, Wolters Kluwer Health - 2012-07-24

Press Mentions

Know Your Skin: Psoriasis Symptoms & Treatment OptionsFebruary 22nd, 2016

Hospital Affiliations

Evanston HospitalEvanston, Illinois
Skokie HospitalSkokie, Illinois
Highland Park HospitalHighland Park, Illinois
Glenbrook HospitalGlenview, Illinois

StephanieMehlisMD

Dr. Mehlis is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.